arrow
V

Violante Di Donato

sapienza university rome
H指数:51
被引数:7,038

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phase 1–3 cross-cultural development and pre-testing of the European Organisation of Research and Treatment of Cancer Vulva cancer questionnaire module (EORTC QLQ- VU)

欧洲癌症研究与治疗组织外阴癌问卷模块(EORTC QLQ-VU)的1-3阶段跨文化开发与预测试

2026-07-230
OAAI
The Microbiota as a Potential Cause of Disease

微生物组作为疾病的潜在病因

2026-07-200
OA
Clinical relevance and prognostic role of PDL-1 expression in cervical cancer patients

PDL-1表达在宫颈癌患者中的临床相关性和预后作用

2026-05-090
OA
Epigallocatechin-Gallate (EGCG): An Essential Molecule for Human Health and Well-Being

Rovaldi, E.; Di Donato, V.; Paolino, G.; Bruno, M.; Medei, A.; Nisticò, S.P.; Pellacani, G.; Kiss, N.; Azzella, G.; Banvolgyi, A.; 等. 表没食子儿茶素没食子酸酯(EGCG):人类健康与福祉的关键分子. Int. J. Mol. Sci. 2025, 26, 9253. [Google Scholar] [CrossRef]

2026-03-030
OAAI
The Impact of Non-Radical Hysterectomy on Urinary Functions: Evaluation of Symptoms—A Systematic Review and Meta-Analysis

非根治性子宫切除术对泌尿功能的影响:症状评估——系统评价与荟萃分析

2025-10-170
OAAI
Correction: Restaino et al. Management of Patients with Vulvar Cancers: A Systematic Comparison of International Guidelines (NCCN–ASCO–ESGO–BGCS–IGCS–FIGO–French Guidelines–RCOG). Cancers 2025, 17, 186

更正:Restaino等人,妇科癌症患者的管理:国际指南的系统比较(NCCN–ASCO–ESGO–BGCS–IGCS–FIGO–法国指南–RCOG)。Cancers 2025, 17, 186

2025-09-270
OAAI
Long term survival analysis of a randomized phase II study of front-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer (QPT-ORE-002).

晚期卵巢癌一线卡铂-紫杉醇化疗联合奥雷戈莫单抗间接免疫接种的随机Ⅱ期研究长期生存分析(QPT-ORE-002)。

2025-09-050
PRE
The Role of Deep Neuromuscular Blockade and Sugammadex in Laparoscopic Hysterectomy: A Randomized Controlled Trial

深神经肌肉阻滞和Sugammadex在腹腔镜子宫切除术中的作用:一项随机对照试验

2025-09-010
OA
Fertility-sparing approach in endometrioid grade II endometrial cancer: the role of molecular classification

子宫内膜样G2期子宫内膜癌的生育力保留策略:分子分型的作用

2025-08-050
PRE
Evaluation of survival and mortality in pelvic exenteration for gynecologic malignancies: a systematic review, meta-analyses, and meta-regression study

妇科恶性肿瘤盆腔脏器切除术后生存率和死亡率的评估:一项系统评价、Meta分析及Meta回归研究

2025-06-010
PRE
Exploring the cost-effectiveness of the OSNA method for patients facing endometrial cancer: Insights from a single-institution experience

探索OSNA方法用于子宫内膜癌患者的成本效益:来自单机构经验的见解

2025-05-310
PRE
Laparoscopic Lateral Suspension (LLS) for Pelvic Organ Prolapse (POP): Update and Systematic Review of Prospective and Randomised Trials

腹腔镜侧方悬吊术(LLS)治疗盆腔器官脱垂(POP):前瞻性和随机试验的更新与系统综述

2025-04-290
OA